Department of Veterans Affairs Medical Center, 50 Irving Street, N.W., Washington, DC 20422

Q -- ADR MONITORING SOL RFP 688-42-00 DUE 122199 POC Joyce Forker, Contracting Officer, (202) 745-8543 This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in FAR subpart 12.6, as supplemented with additional information included in this notice (SIC 8099). This announcement constitutes the only solicitation, Request For Proposal (RFP) being requested and a written solicitation will not be issued. Solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular #90-42. Offeror shall submit proposal for developing a clinical pharmacy service in the areas of Drug Utilization Evaluation (DUE) and Adverse Drug Reactions (ADR). Submitted proposals should indicate strategies to provide comprehensive clinical support to the Pharmacy Service in the two (2) previously mentioned programs: ADR Monitoring Program: 1. Identify and evaluate retrospectively and prospectively suspected ADR's, 2. expand the existing screening program and conduct activities to foster the detection of ADR as outlined in VAMC policy andprocedures, 3. analyze and summarize monthly ADR data, 4. assist in the research and development of enhances systems in ADR detection, evaluation, and reporting, 5. Attend the ADR subcommittee meetings and perform committee activities as required, 6. provide drug information support to the VA staff as required for critical evaluation of ADR, 7. assist in the compilation of reports and presentation materials for review by agencies, i.e. JCAHO. DUE Program: prepare in concert with the DUE subcommittee an annual DUE plan for the VAMC,. 2. develop, in concert with the medical staff, the study criteria and data collection tools for each study as required, 3. assist in conducting the DUE studies which include retrospective and or prospective data collection (and occasionally clinical intervention), analysis of findings, and development or recommendations and conclusions, 4. attend the DUE subcommittee meetings and perform committee activities as required including study presentations, 5. conduct meetings with members of the medical, dental, quality assurance or nursing service as required to facilitate completion of studies, 6. assist in the development and implementation of action plan based on DUE study results; these may include guideline development, newsletter article submission, etc., 7. assist in the compilation of reports and presentation materials for review by agencies, i.e. JCAHO. Offerors should provide documentation for evaluation criteria for the following: A. Education. contractor personnel should: 1. be graduates of a degree program in pharmacy from an American Council on Pharmaceutical Education (ACPE) approved college or university, 2. possess a Pharm. D. or formal post-baccalaureate (M.S., Pharm.D., Ph.D.) hospital oriented degree program recognized by ACPE (or demonstrate equivocal experience), 3. demonstrate advance knowledge of pharmacotherapeutics, pharmacokinetics, patient drug therapy outcome monitoring, drug research design, and the standards related to distribution and control of schedule and non-schedule drugs (i.e. DEA, FDA, VA, JCAHO standards), 4. possess the ability to communicate orally and in writing with a wide variety of individuals (i.e. health care professionals, patients), 5. Full, current and unrestricted license to practice pharmacy in a State, Territory, Commonwealth of the United States (i.e. Puerto Rico), or the District of Columbia. B. Quality of Offeror's Facility/Resources: The offeror should provide descriptive information to include, but not limited to, manpower/staffing, drug information capabilities, secretarial support, and computerization support. C. Management Capabilities and Approach: The offeror should describe management methods to assure the provision of prompt and quality service, including a description of a quality assurance and customer service plan tailored towards this solicitation. D. Past Performance: The offeror should identify all Federal, State, and local government contracts and private contracts of similar scope, size, and complexity that are ongoing, or have been completed within the past 3 years. Provide a list of references pertaining to those contracts. Acceptance time will be 60 days from bid opening date. This will be a firm fixed-price contract. Payment will be made in arrears on certified invoices. The following clauses and provisions are incorporated and applicable to this acquisition: 52.212-1 Instructions to Offerors -- Commercial, 52.212-3 Offeror Representations and Certifications -- Commercial Items, 52.212-4 Contract Terms and Conditions -- Commercial Items, 52.212-5 Contract Terms and Conditions Required To Implement Statutes or Executive Orders -- Commercial Items, 52.232-19 Availability of Funds For Next Fiscal Year, 52.232-33 Mandatory Information For Electronic Funds Transfer Payment. Original proposals shall be received no later than 4:00p.m. EST, December 21, 1999 and submitted on company letterhead to: Joyce Forker, Contracting Officer 90C, VAMC, 50 Irving St.,NW, Washington, DC 20422. FAXED requests will not be accepted. This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in FAR subpart 12.6, as supplemented with additional information included in this notice (SIC 8099). This announcement constitutes the only solicitation, Request For Proposal (RFP) being requested and a written solicitation will not be issued. Solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular #90-42. Offeror shall submit proposal for developing a clinical pharmacy service in the areas of Drug Utilization Evaluation (DUE) and Adverse Drug Reactions (ADR). Submitted proposals should indicate strategies to provide comprehensive clinical support to the Pharmacy Service in the two (2) previously mentioned programs: ADR Monitoring Program: 1. Identify and evaluate retrospectively and prospectively suspected ADR's, 2. expand the existing screening program and conduct activities to foster the detection of ADR as outlined in VAMC policy and procedures, 3. analyze and summarize monthly ADR data, 4. assist in the research and development of enhances systems in ADR detection, evaluation, and reporting, 5. Attend the ADR subcommittee meetings and perform committee activities as required, 6. provide drug information support to the VA staff as required for critical evaluation of ADR, 7. assist in the compilation of reports and presentation materials for review by agencies, i.e. JCAHO. DUE Program: prepare in concert with the DUE subcommittee an annual DUE plan for the VAMC,. 2. develop, in concert with the medical staff, the study criteria and data collection tools for each study as required, 3. assist in conducting the DUE studies which include retrospective and or prospective data collection (and occasionally clinical intervention), analysis of findings, and development or recommendations and conclusions, 4. attend the DUE subcommittee meetings and perform committee activities as required including study presentations, 5. conduct meetings with members of the medical, dental, quality assurance or nursing service as required to facilitate completion of studies, 6. assist in the development and implementation of action plan based on DUE study results; these may include guideline development, newsletter article submission, etc., 7. assist in the compilation of reports and presentation materials for review by agencies, i.e. JCAHO. Offerors should provide documentation for evaluation criteria for the following: A. Education. contractor personnel should: 1. be graduates of a degree program in pharmacy from an American Council on Pharmaceutical Education (ACPE) approved college or university, 2. possess a Pharm. D. or formal post-baccalaureate (M.S., Pharm.D., Ph.D.) hospital oriented degree program recognized by ACPE (or demonstrate equivocal experience), 3. demonstrate advance knowledge of pharmacotherapeutics, pharmacokinetics, patient drug therapy outcome monitoring, drug research design, and the standards related to distribution and control of schedule and non-schedule drugs (i.e. DEA, FDA, VA, JCAHO standards), 4. possess the ability to communicate orally and in writing with a wide variety of individuals (i.e. health care professionals, patients), 5. Full, current and unrestricted license to practice pharmacy in a State, Territory, Commonwealth of the United States (i.e. Puerto Rico), or the District of Columbia. B. Quality of Offeror's Facility/Resources: The offeror should provide descriptive information to include, but not limited to, manpower/staffing, drug information capabilities, secretarial support, and computerization support. C. Management Capabilities and Approach: The offeror should describe management methods to assure the provision of prompt and quality service, including a description of a quality assurance and customer service plan tailored towards this solicitation. D. Past Performance: The offeror should identify all Federal, State, and local government contracts and private contracts of similar scope, size, and complexity that are ongoing, orhave been completed within the past 3 years. Provide a list of references pertaining to those contracts. Acceptance time will be 60 days from bid opening date. This will be a firm fixed-price contract. Payment will be made in arrears on certified invoices. The following clauses and provisions are incorporated and applicable to this acquisition: 52.212-1 Instructions to Offerors -- Commercial, 52.212-3 Offeror Representations and Certifications -- Commercial Items, 52.212-4 Contract Terms and Conditions -- Commercial Items, 52.212-5 Contract Terms and Conditions Required To Implement Statutes or Executive Orders -- Commercial Items, 52.232-19 Availability of Funds For Next Fiscal Year, 52.232-33 Mandatory Information For Electronic Funds Transfer Payment. Original proposals shall be received no later than 4:00p.m. EST, December 21, 1999 and submitted on company letterhead to: Joyce Forker, Contracting Officer 90C, VAMC, 50 Irving St.,NW, Washington, DC 20422. FAXED requests will not be accepted. Posted 12/07/99 (W-SN406468). (0341)

Loren Data Corp. http://www.ld.com (SYN# 0050 19991209\Q-0003.SOL)